324 related articles for article (PubMed ID: 29527530)
1. Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases.
Palzkill T
Front Mol Biosci; 2018; 5():16. PubMed ID: 29527530
[TBL] [Abstract][Full Text] [Related]
2. Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability.
Mehta SC; Rice K; Palzkill T
PLoS Pathog; 2015 Jun; 11(6):e1004949. PubMed ID: 26030609
[TBL] [Abstract][Full Text] [Related]
3. Mapping the determinants of catalysis and substrate specificity of the antibiotic resistance enzyme CTX-M β-lactamase.
Judge A; Hu L; Sankaran B; Van Riper J; Venkataram Prasad BV; Palzkill T
Commun Biol; 2023 Jan; 6(1):35. PubMed ID: 36635385
[TBL] [Abstract][Full Text] [Related]
4. Natural variants modify Klebsiella pneumoniae carbapenemase (KPC) acyl-enzyme conformational dynamics to extend antibiotic resistance.
Tooke CL; Hinchliffe P; Bonomo RA; Schofield CJ; Mulholland AJ; Spencer J
J Biol Chem; 2021; 296():100126. PubMed ID: 33257320
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis and structural analysis reveal the CTX-M β-lactamase active site is optimized for cephalosporin catalysis and drug resistance.
Lu S; Montoya M; Hu L; Neetu N; Sankaran B; Prasad BVV; Palzkill T
J Biol Chem; 2023 May; 299(5):104630. PubMed ID: 36963495
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.
Patel MP; Fryszczyn BG; Palzkill T
Antimicrob Agents Chemother; 2015 Nov; 59(11):6741-8. PubMed ID: 26282414
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.
Patel MP; Hu L; Brown CA; Sun Z; Adamski CJ; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
J Biol Chem; 2018 Nov; 293(46):17971-17984. PubMed ID: 30275013
[TBL] [Abstract][Full Text] [Related]
8. A triple mutant in the Ω-loop of TEM-1 β-lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis.
Stojanoski V; Chow DC; Hu L; Sankaran B; Gilbert HF; Prasad BV; Palzkill T
J Biol Chem; 2015 Apr; 290(16):10382-94. PubMed ID: 25713062
[TBL] [Abstract][Full Text] [Related]
9. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
Stürenburg E; Kühn A; Mack D; Laufs R
J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
[TBL] [Abstract][Full Text] [Related]
10. The Drug-Resistant Variant P167S Expands the Substrate Profile of CTX-M β-Lactamases for Oxyimino-Cephalosporin Antibiotics by Enlarging the Active Site upon Acylation.
Patel MP; Hu L; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
Biochemistry; 2017 Jul; 56(27):3443-3453. PubMed ID: 28613873
[TBL] [Abstract][Full Text] [Related]
11. Class D β-lactamases: a reappraisal after five decades.
Leonard DA; Bonomo RA; Powers RA
Acc Chem Res; 2013 Nov; 46(11):2407-15. PubMed ID: 23902256
[TBL] [Abstract][Full Text] [Related]
12. Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability.
Chen Y; Delmas J; Sirot J; Shoichet B; Bonnet R
J Mol Biol; 2005 Apr; 348(2):349-62. PubMed ID: 15811373
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of extended spectrum beta lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Gram negative bacilli isolates from pediatric patient population in Gaza strip.
El Aila NA; Al Laham NA; Ayesh BM
BMC Infect Dis; 2023 Feb; 23(1):99. PubMed ID: 36803466
[TBL] [Abstract][Full Text] [Related]
14. Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance.
Novais A; Cantón R; Coque TM; Moya A; Baquero F; Galán JC
Antimicrob Agents Chemother; 2008 Jul; 52(7):2377-82. PubMed ID: 18443114
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N
Ourghanlian C; Soroka D; Arthur M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069651
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases.
Adamski CJ; Cardenas AM; Brown NG; Horton LB; Sankaran B; Prasad BV; Gilbert HF; Palzkill T
Biochemistry; 2015 Jan; 54(2):447-57. PubMed ID: 25489790
[TBL] [Abstract][Full Text] [Related]
17.
Barnes MD; Winkler ML; Taracila MA; Page MG; Desarbre E; Kreiswirth BN; Shields RK; Nguyen MH; Clancy C; Spellberg B; Papp-Wallace KM; Bonomo RA
mBio; 2017 Oct; 8(5):. PubMed ID: 29089425
[TBL] [Abstract][Full Text] [Related]
18. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
Walther-Rasmussen J; Høiby N
Can J Microbiol; 2004 Mar; 50(3):137-65. PubMed ID: 15105882
[TBL] [Abstract][Full Text] [Related]
19. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
20. Antagonism between substitutions in β-lactamase explains a path not taken in the evolution of bacterial drug resistance.
Brown CA; Hu L; Sun Z; Patel MP; Singh S; Porter JR; Sankaran B; Prasad BVV; Bowman GR; Palzkill T
J Biol Chem; 2020 May; 295(21):7376-7390. PubMed ID: 32299911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]